Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Romics

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Orvosi Hetilap|April 23, 2009
[Prevention and treatment of erectile dysfunction after radical prostatectomy]Péter Riesz, András Rusz, Miklós Szucs, et al.
Orvosi Hetilap|September 11, 2007
[Experiences in treatment and follow up of 50 patients with penile cancer]Péter Riesz, Péter Nyirády, Miklós Szucs, et al.
Cancer Science|February 26, 2010
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancerTibor Szarvas, Markus Becker, Frank vom Dorp, et al.
Pathology Oncology Research : POR|October 9, 2007
Detection of bladder cancer from the urine using fluorescence in situ hybridization techniquePéter Riesz, Gábor Lotz, Csilla Páska, et al.
International Journal of Cancer|May 18, 2010
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomyTibor Szarvas, Markus Becker, Frank Vom Dorp, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|August 12, 2011
Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladderEszter Székely, Péter Törzsök, Péter Riesz, et al.
BJU International|April 17, 2012
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancerTibor Szarvas, Frank vom Dorp, Christian Niedworok, et al.
Journal of Translational Medicine|June 10, 2010
The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trialMaximilian Burger, Nicolas Thiounn, Stefan Denzinger, et al.
Archives of Toxicology|April 26, 2012
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer riskSilvia Selinski, Marie-Louise Lehmann, Meinolf Blaszkewicz, et al.
Pharmacogenetics and Genomics|July 14, 2011
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotypeSilvia Selinski, Meinolf Blaszkewicz, Marie-Louise Lehmann, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Orvosi Hetilap|April 23, 2009
[Prevention and treatment of erectile dysfunction after radical prostatectomy]Péter Riesz, András Rusz, Miklós Szucs, et al.
Orvosi Hetilap|September 11, 2007
[Experiences in treatment and follow up of 50 patients with penile cancer]Péter Riesz, Péter Nyirády, Miklós Szucs, et al.
Cancer Science|February 26, 2010
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancerTibor Szarvas, Markus Becker, Frank vom Dorp, et al.
Pathology Oncology Research : POR|October 9, 2007
Detection of bladder cancer from the urine using fluorescence in situ hybridization techniquePéter Riesz, Gábor Lotz, Csilla Páska, et al.
International Journal of Cancer|May 18, 2010
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomyTibor Szarvas, Markus Becker, Frank Vom Dorp, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|August 12, 2011
Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladderEszter Székely, Péter Törzsök, Péter Riesz, et al.
BJU International|April 17, 2012
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancerTibor Szarvas, Frank vom Dorp, Christian Niedworok, et al.
Journal of Translational Medicine|June 10, 2010
The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trialMaximilian Burger, Nicolas Thiounn, Stefan Denzinger, et al.
Archives of Toxicology|April 26, 2012
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer riskSilvia Selinski, Marie-Louise Lehmann, Meinolf Blaszkewicz, et al.
Pharmacogenetics and Genomics|July 14, 2011
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotypeSilvia Selinski, Meinolf Blaszkewicz, Marie-Louise Lehmann, et al.
Pageof 8